-- High Tide (HITI.V, HITI) reported preliminary tonnage data from its 51%-owned German subsidiary, Remexian Pharma GmbH, for the second fiscal quarter ended April 30, 2026, on Wednesday.
Remexian sold 7.6 tonnes of medical cannabis into the German market during the quarter, representing the "highest quarterly distribution volume in its history," stated the company.
Volumes increased 21% on a sequential basis and 49% year over year, it added.
"Distributing 7.6 tonnes in a single quarter is not just a record for Remexian - it is clear evidence that our model is scaling in the largest medical cannabis market in Europe," said Raj Grover, Founder and Chief Executive Officer of High Tide.
"This level of sequential and year-over-year growth reinforces our conviction that Germany is only the beginning. We are building a repeatable, capital-efficient distribution engine that can be expanded across Europe, subject to regulatory conditions. We fully intend to leverage this momentum to continue taking share in Germany while methodically entering additional high-growth markets," added Grover.